1	INTRODUCTION	23
1.1	STUDY OBJECTIVES	23
1.2	MARKET DEFINITION	23
1.2.1	INCLUSIONS AND EXCLUSIONS	23
1.3	MARKET SCOPE	24
1.3.1	MARKETS COVERED	24
1.3.2	REGIONS COVERED	24
1.3.3	YEARS CONSIDERED	25
1.3.4	CURRENCY CONSIDERED	25
TABLE 1	EXCHANGE RATES UTILIZED FOR CONVERSION TO USD	25
1.4	STAKEHOLDERS	25
1.5	SUMMARY OF CHANGES	26
1.5.1	RECESSION IMPACT	27
2	RESEARCH METHODOLOGY	28
2.1	RESEARCH APPROACH	28
FIGURE 1	RESEARCH DESIGN	28
FIGURE 2	ELECTROPHYSIOLOGY MARKET: MARKET GROWTH IMPACT ANALYSIS	29
2.1.1	SECONDARY DATA	29
2.1.1.1	Key data from secondary sources	30
2.1.2	PRIMARY DATA	31
2.1.2.1	Primary sources	31
2.1.2.2	Breakdown of primaries	32
FIGURE 3	BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION	32
2.2	MARKET SIZE ESTIMATION	32
FIGURE 4	MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION	33
2.2.1	END USER-BASED MARKET ESTIMATION	33
FIGURE 5	MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION	33
FIGURE 6	BOTTOM-UP APPROACH	34
FIGURE 7	TOP-DOWN APPROACH	34
2.3	MARKET BREAKDOWN & DATA TRIANGULATION	36
FIGURE 8	DATA TRIANGULATION METHODOLOGY	36
2.4	LIMITATIONS	37
2.5	RISK ASSESSMENT	37
2.6	STUDY ASSUMPTIONS	37
2.7	ELECTROPHYSIOLOGY MARKET: RECESSION IMPACT ANALYSIS	38
3	EXECUTIVE SUMMARY	39
FIGURE 9	ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)	39
FIGURE 10	ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023 VS. 2028 (USD MILLION)	40
FIGURE 11	ELECTROPHYSIOLOGY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)	41
FIGURE 12	ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD (2023–2028)	42
4	PREMIUM INSIGHTS	43
4.1	ELECTROPHYSIOLOGY MARKET OVERVIEW	43
FIGURE 13	TECHNOLOGICAL ADVANCEMENTS TO DRIVE GLOBAL ELECTROPHYSIOLOGY MARKET GROWTH	43
4.2	GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION	44
FIGURE 14	ATRIAL FIBRILLATION SEGMENT DOMINATED ELECTROPHYSIOLOGY MARKET IN 2022	44
4.3	ELECTROPHYSIOLOGY MARKET: GEOGRAPHICAL SNAPSHOT	45
FIGURE 15	CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (2023–2028)	45
5	MARKET OVERVIEW	46
5.1	INTRODUCTION	46
5.2	MARKET DYNAMICS	46
FIGURE 16	ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES	46
5.2.1	DRIVERS	47
5.2.1.1	Technological advancements	47
5.2.1.1.1	Rising use of noninvasive cardiac mapping	47
5.2.1.1.2	Increased use of improved intracardiac ablation systems	47
5.2.1.1.3	Increased use of MRI-guided ablation procedures	48
5.2.1.1.4	Growing level of ultrasound guidance in EP labs	48
5.2.1.2	Rising number of new entrants	49
5.2.1.3	Growing investments, funds, and grants for cardiac surgeries and electrophysiology	49
5.2.1.4	Increasing disease incidence and procedural volume	49
5.2.2	RESTRAINTS	50
5.2.2.1	High product cost and inadequate reimbursement	50
5.2.2.2	Unfavorable healthcare reforms in US	51
5.2.2.3	Cost-intensive data requirements for product launches and availability of alternative technologies	51
5.2.3	OPPORTUNITIES	51
5.2.3.1	Emerging markets	51
5.2.4	CHALLENGES	52
5.2.4.1	Increasing device reuse and reprocessing	52
5.2.4.2	Lack of skilled and experienced personnel	53
5.3	PORTER’S FIVE FORCES ANALYSIS	53
TABLE 2	ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS	53
5.3.1	THREAT OF NEW ENTRANTS	54
5.3.2	THREAT OF SUBSTITUTES	54
5.3.3	BARGAINING POWER OF SUPPLIERS	54
5.3.4	BARGAINING POWER OF BUYERS	54
5.3.5	INTENSITY OF COMPETITIVE RIVALRY	55
5.4	ECOSYSTEM/MARKET MAP	55
FIGURE 17	ELECTROPHYSIOLOGY MARKET: ECOSYSTEM/MARKET MAP	55
5.5	VALUE CHAIN ANALYSIS	56
5.5.1	RESEARCH & DEVELOPMENT	56
5.5.2	PROCUREMENT AND PRODUCT DEVELOPMENT	56
5.5.3	MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES	56
FIGURE 18	ELECTROPHYSIOLOGY MARKET: VALUE CHAIN ANALYSIS	56
5.6	SUPPLY CHAIN ANALYSIS	57
5.6.1	PROMINENT COMPANIES	57
5.6.2	END USERS	57
FIGURE 19	ELECTROPHYSIOLOGY MARKET: SUPPLY CHAIN ANALYSIS	57
5.7	TARIFF & REGULATORY LANDSCAPE	57
5.7.1	NORTH AMERICA	57
5.7.1.1	US	57
TABLE 3	CLASSIFICATION OF MEDICAL DEVICES BY US FDA (2022)	58
TABLE 4	US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2022)	58
5.7.1.2	Canada	59
TABLE 5	CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2022)	59
5.7.2	EUROPE	59
5.7.3	ASIA PACIFIC	60
5.7.3.1	India	60
5.7.3.2	China	61
TABLE 6	CHINA: NMPA CLASSIFICATION OF MEDICAL DEVICES (2022)	61
5.7.3.3	Japan	61
TABLE 7	JAPAN: PMDA CLASSIFICATION OF MEDICAL DEVICES (2022)	62
5.7.4	REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	62
TABLE 8	NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	62
TABLE 9	EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	63
TABLE 10	ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	63
TABLE 11	REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	64
5.8	REIMBURSEMENT SCENARIO	64
TABLE 12	ELECTROPHYSIOLOGY MARKET: CPT CODES	64
5.9	PRICING ANALYSIS	66
5.9.1	AVERAGE PRICE OF ELECTROPHYSIOLOGY PRODUCTS, 2022 (USD)	66
5.10	TECHNOLOGY ANALYSIS	67
TABLE 13	ELECTROPHYSIOLOGY MARKET: PROMINENT PRODUCT LAUNCHES (JANUARY 2019–DECEMBER 2023)	67
5.11	PATENT ANALYSIS	67
5.11.1	PATENTS GRANTED FOR ELECTROPHYSIOLOGY	67
FIGURE 20	ELECTROPHYSIOLOGY MARKET: TOP 10 PATENT APPLICANTS	68
FIGURE 21	ELECTROPHYSIOLOGY MARKET: TOP 10 PATENT OWNERS	69
5.12	KEY CONFERENCES AND EVENTS IN 2023–2024	69
TABLE 14	ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS	69
5.13	KEY STAKEHOLDERS AND BUYING CRITERIA	70
5.13.1	KEY STAKEHOLDERS IN BUYING PROCESS, BY END USER	70
FIGURE 22	INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER	70
TABLE 15	INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)	70
5.13.2	BUYING CRITERIA	70
FIGURE 23	KEY BUYING CRITERIA, BY END USER	70
TABLE 16	KEY BUYING CRITERIA, BY STAKEHOLDER	71
5.14	ELECTROPHYSIOLOGY MARKET: UNMET NEEDS	71
6	ELECTROPHYSIOLOGY MARKET, BY PRODUCT	73
6.1	INTRODUCTION	74
TABLE 17	ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	74
6.2	LABORATORY DEVICES	75
TABLE 18	ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	75
TABLE 19	ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY INDICATION, 2021–2028 (USD MILLION)	75
TABLE 20	ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)	76
TABLE 21	ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)	76
6.2.1	3D MAPPING SYSTEMS	77
6.2.1.1	Development of alternative technologies to hinder market growth	77
TABLE 22	3D MAPPING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)	77
6.2.2	RECORDING SYSTEMS	78
6.2.2.1	Increasing public-private funding to support growth	78
TABLE 23	RECORDING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)	78
6.2.3	RF ABLATION SYSTEMS	79
6.2.3.1	Rising number of RF ablation procedures to drive market	79
TABLE 24	RF ABLATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)	79
6.2.4	ICE ULTRASOUND IMAGING SYSTEMS	80
6.2.4.1	Advantages of ICE ultrasound imaging to drive market	80
TABLE 25	ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)	80
6.2.5	X-RAY SYSTEMS	81
6.2.5.1	Growing availability of magnetic navigation systems to hamper market growth	81
TABLE 26	X-RAY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)	81
6.2.6	REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS	81
6.2.6.1	Favorable reimbursement scenario to drive market	81
TABLE 27	REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)	82
6.3	ABLATION CATHETERS	83
TABLE 28	ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	83
TABLE 29	ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY INDICATION, 2021–2028 (USD MILLION)	83
TABLE 30	ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY END USER, 2021–2028 (USD MILLION)	84
TABLE 31	ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)	84
6.3.1	CRYOABLATION CATHETERS	85
6.3.1.1	Significant therapeutic advantages to drive market	85
TABLE 32	CRYOABLATION CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)	85
6.3.2	RF ABLATION CATHETERS	86
6.3.2.1	Technological advancements to drive market	86
TABLE 33	RF ABLATION CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)	86
6.3.3	MWA SYSTEMS	86
6.3.3.1	Advantages of microwave ablation over RF to support growth	86
TABLE 34	COMPARISON OF MICROWAVE AND RADIOFREQUENCY ABLATION	87
TABLE 35	MWA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)	87
6.3.4	LASER ABLATION SYSTEMS	88
6.3.4.1	Technologically advanced products to drive market	88
TABLE 36	LASER ABLATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)	88
6.4	DIAGNOSTIC CATHETERS	89
TABLE 37	ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	89
TABLE 38	ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY INDICATION, 2021–2028 (USD MILLION)	89
TABLE 39	ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY END USER, 2021–2028 (USD MILLION)	90
TABLE 40	ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)	90
6.4.1	CONVENTIONAL DIAGNOSTIC CATHETERS	91
6.4.1.1	Increasing demand in emerging markets to support market growth	91
TABLE 41	CONVENTIONAL DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)	91
6.4.2	ADVANCED DIAGNOSTIC CATHETERS	92
6.4.2.1	Advantages over conventional catheters to drive market	92
TABLE 42	ADVANCED DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)	92
6.4.3	ULTRASOUND DIAGNOSTIC CATHETERS	92
6.4.3.1	Increased demand due to the rising use of ICE ultrasound imaging to drive market	92
TABLE 43	ULTRASOUND DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)	93
6.5	ACCESS DEVICES	93
6.5.1	LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET	93
TABLE 44	ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY INDICATION, 2021–2028 (USD MILLION)	94
TABLE 45	ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)	94
TABLE 46	ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)	95
6.6	OTHER PRODUCTS	95
TABLE 47	OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY INDICATION, 2021–2028 (USD MILLION)	95
TABLE 48	OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY END USER, 2021–2028 (USD MILLION)	96
TABLE 49	OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)	96
7	ELECTROPHYSIOLOGY MARKET, BY INDICATION	97
7.1	INTRODUCTION	98
TABLE 50	ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION)	98
7.2	ATRIAL FIBRILLATION	98
7.2.1	GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET	98
TABLE 51	ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2021–2028 (USD MILLION)	99
7.3	ATRIAL FLUTTER	100
7.3.1	HIGH SUCCESS RATE OF RF CATHETER ABLATION TO DRIVE MARKET	100
TABLE 52	ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION, 2021–2028 (USD MILLION)	100
7.4	ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA	101
7.4.1	EFFICACY OF ELECTROPHYSIOLOGY DEVICES IN AVNRT APPLICATIONS TO DRIVE MARKET	101
TABLE 53	ELECTROPHYSIOLOGY MARKET FOR AVNRT, BY REGION, 2021–2028 (USD MILLION)	101
7.5	WOLFF-PARKINSON-WHITE SYNDROME	102
7.5.1	GROWING PREFERENCE FOR RF ABLATION TREATMENT OVER SURGERY TO DRIVE MARKET	102
TABLE 54	ELECTROPHYSIOLOGY MARKET FOR WPW SYNDROME, BY REGION, 2021–2028 (USD MILLION)	102
7.6	OTHER INDICATIONS	103
TABLE 55	ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION, 2021–2028 (USD MILLION)	103
8	ELECTROPHYSIOLOGY MARKET, BY END USER	104
8.1	INTRODUCTION	105
TABLE 56	ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)	105
8.2	HOSPITALS & CARDIAC CENTERS	105
8.2.1	HOSPITAL & CARDIAC CENTERS TO DOMINATE END-USER MARKET	105
TABLE 57	ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2021–2028 (USD MILLION)	106
8.3	AMBULATORY SURGERY CENTERS	106
8.3.1	INCREASING NUMBER OF CENTERS TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES	106
TABLE 58	ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021–2028 (USD MILLION)	107
9	ELECTROPHYSIOLOGY MARKET, BY REGION	108
9.1	INTRODUCTION	109
TABLE 59	ELECTROPHYSIOLOGY MARKET, BY REGION, 2021–2028 (USD MILLION)	109
9.2	NORTH AMERICA	110
FIGURE 24	NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT	110
9.2.1	NORTH AMERICA: RECESSION IMPACT	111
TABLE 60	NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	111
TABLE 61	NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	111
TABLE 62	NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	112
TABLE 63	NORTH AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	112
TABLE 64	NORTH AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	113
TABLE 65	NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION)	113
TABLE 66	NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)	114
9.2.2	US	114
9.2.2.1	Technological advancements to drive market growth	114
TABLE 67	US: CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES	114
TABLE 68	US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	115
TABLE 69	US: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	116
TABLE 70	US: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	116
TABLE 71	US: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	117
9.2.3	CANADA	117
9.2.3.1	Growing government funding for research to support market growth	117
TABLE 72	RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY	118
TABLE 73	CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	119
TABLE 74	CANADA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	119
TABLE 75	CANADA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	120
TABLE 76	CANADA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	120
9.3	EUROPE	121
9.3.1	EUROPE: RECESSION IMPACT	121
TABLE 77	EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	121
TABLE 78	EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	122
TABLE 79	EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	122
TABLE 80	EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	123
TABLE 81	EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	123
TABLE 82	EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION)	124
TABLE 83	EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)	124
9.3.2	GERMANY	125
9.3.2.1	Rising healthcare expenditure and growing use of electrophysiology devices to drive market	125
TABLE 84	GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	125
TABLE 85	GERMANY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	126
TABLE 86	GERMANY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	126
TABLE 87	GERMANY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	127
9.3.3	UK	127
9.3.3.1	Growing geriatric population to drive market	127
TABLE 88	UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	128
TABLE 89	UK: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	128
TABLE 90	UK: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	129
TABLE 91	UK: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	129
9.3.4	FRANCE	129
9.3.4.1	Increasing incidence of heart failure to support market growth	129
TABLE 92	FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	130
TABLE 93	FRANCE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	130
TABLE 94	FRANCE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	131
TABLE 95	FRANCE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	131
9.3.5	ITALY	131
9.3.5.1	Rising incidence of CVD to drive electrophysiology device adoption	131
TABLE 96	ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	132
TABLE 97	ITALY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	132
TABLE 98	ITALY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	133
TABLE 99	ITALY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	133
9.3.6	SPAIN	134
9.3.6.1	Growing number of cardiac ablation procedures to drive market growth	134
TABLE 100	SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	134
TABLE 101	SPAIN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	134
TABLE 102	SPAIN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	135
TABLE 103	SPAIN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	135
9.3.7	REST OF EUROPE	135
TABLE 104	REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	136
TABLE 105	REST OF EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	136
TABLE 106	REST OF EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	137
TABLE 107	REST OF EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	137
 
9.4	ASIA PACIFIC	138
9.4.1	ASIA PACIFIC: RECESSION IMPACT	138
FIGURE 25	ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT	139
TABLE 108	ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	140
TABLE 109	ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	140
TABLE 110	ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	141
TABLE 111	ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	141
TABLE 112	ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	142
TABLE 113	ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION)	142
TABLE 114	ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)	143
9.4.2	JAPAN	143
9.4.2.1	Favorable reimbursement scenario to support market growth	143
TABLE 115	JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	144
TABLE 116	JAPAN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	144
TABLE 117	JAPAN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	145
TABLE 118	JAPAN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	145
9.4.3	CHINA	146
9.4.3.1	Growing geriatric population to drive market	146
TABLE 119	CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	146
TABLE 120	CHINA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	147
TABLE 121	CHINA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	147
TABLE 122	CHINA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	148
9.4.4	INDIA	148
9.4.4.1	Increasing healthcare initiatives by government to drive market growth	148
TABLE 123	INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	148
TABLE 124	INDIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	149
TABLE 125	INDIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	149
 
TABLE 126	INDIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	150
9.4.5	AUSTRALIA	150
9.4.5.1	Increasing target disease burden to support market growth	150
TABLE 127	AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	151
TABLE 128	AUSTRALIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	151
TABLE 129	AUSTRALIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	152
TABLE 130	AUSTRALIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	152
9.4.6	SOUTH KOREA	153
9.4.6.1	Supportive government initiatives to drive market growth	153
TABLE 131	SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	153
TABLE 132	SOUTH KOREA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	153
TABLE 133	SOUTH KOREA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	154
TABLE 134	SOUTH KOREA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	154
9.4.7	REST OF ASIA PACIFIC	154
TABLE 135	REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	155
TABLE 136	REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	155
TABLE 137	REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	156
TABLE 138	REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	156
9.5	LATIN AMERICA	156
9.5.1	LATIN AMERICA: RECESSION IMPACT	157
TABLE 139	LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	157
TABLE 140	LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	157
TABLE 141	LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	158
TABLE 142	LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	158
TABLE 143	LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	159
TABLE 144	LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION)	159
TABLE 145	LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)	160
 
9.5.2	BRAZIL	160
9.5.2.1	Modernization of healthcare facilities to drive market growth	160
TABLE 146	BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	160
TABLE 147	BRAZIL: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	161
TABLE 148	BRAZIL: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	161
TABLE 149	BRAZIL: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	162
9.5.3	MEXICO	162
9.5.3.1	Favorable investment scenario for medical device manufacturers to drive market	162
TABLE 150	MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	163
TABLE 151	MEXICO: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	163
TABLE 152	MEXICO: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	164
TABLE 153	MEXICO: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	164
9.5.4	REST OF LATIN AMERICA	165
TABLE 154	REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	165
TABLE 155	REST OF LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	165
TABLE 156	REST OF LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	166
TABLE 157	REST OF LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	166
9.6	MIDDLE EAST & AFRICA	167
9.6.1	RISING POPULATION AND DISEASE INCIDENCE TO ATTRACT MARKET PLAYERS	167
9.6.2	MIDDLE EAST & AFRICA: RECESSION IMPACT	167
TABLE 158	MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)	168
TABLE 159	MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	168
TABLE 160	MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	169
TABLE 161	MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)	169
TABLE 162	MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021–2028 (USD MILLION)	170
TABLE 163	MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)	170
 
10	COMPETITIVE LANDSCAPE	171
10.1	KEY PLAYER STRATEGIES/RIGHT TO WIN	171
FIGURE 26	OVERVIEW OF STRATEGIES DEPLOYED BY ELECTROPHYSIOLOGY MARKET PLAYERS	171
10.2	REVENUE SHARE ANALYSIS	172
FIGURE 27	REVENUE SHARE ANALYSIS OF TOP PLAYERS, 2020–2022	172
10.3	MARKET SHARE ANALYSIS	173
FIGURE 28	ELECTROPHYSIOLOGY MARKET SHARE ANALYSIS, 2022	173
TABLE 164	ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION	173
10.4	COMPANY EVALUATION MATRIX	174
10.4.1	STARS	174
10.4.2	EMERGING LEADERS	175
10.4.3	PERVASIVE PLAYERS	175
10.4.4	PARTICIPANTS	175
FIGURE 29	ELECTROPHYSIOLOGY MARKET: COMPETITIVE EVALUATION MATRIX, 2022	175
10.4.5	COMPANY FOOTPRINT	176
TABLE 165	PRODUCT FOOTPRINT	176
TABLE 166	END-USER FOOTPRINT	177
TABLE 167	REGIONAL FOOTPRINT	178
10.5	START-UP/SME EVALUATION MATRIX	179
10.5.1	PROGRESSIVE COMPANIES	179
10.5.2	RESPONSIVE COMPANIES	179
10.5.3	DYNAMIC COMPANIES	179
10.5.4	STARTING BLOCKS	179
FIGURE 30	ELECTROPHYSIOLOGY MARKET: START-UP/SME EVALUATION MATRIX, 2022	180
10.5.5	COMPETITIVE BENCHMARKING	181
TABLE 168	ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY START-UPS/SMES	181
TABLE 169	ELECTROPHYSIOLOGY MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES	182
10.6	COMPETITIVE SCENARIO AND TRENDS	183
10.6.1	PRODUCT LAUNCHES & APPROVALS	183
TABLE 170	ELECTROPHYSIOLOGY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–DECEMBER 2023	183
10.6.2	DEALS	183
TABLE 171	ELECTROPHYSIOLOGY MARKET: DEALS, JANUARY 2019–DECEMBER 2023	183
 
11	COMPANY PROFILES	185
(Business overview, Products/Solutions/Services offered, Recent developments & MnM View)*
11.1	KEY PLAYERS	185
11.1.1	JOHNSON & JOHNSON	185
TABLE 172	JOHNSON & JOHNSON: COMPANY OVERVIEW	185
FIGURE 31	JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)	186
11.1.2	ABBOTT LABORATORIES	190
TABLE 173	ABBOTT LABORATORIES: COMPANY OVERVIEW	190
FIGURE 32	ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)	191
11.1.3	MEDTRONIC PLC	194
TABLE 174	MEDTRONIC PLC: COMPANY OVERVIEW	194
FIGURE 33	MEDTRONIC PLC: COMPANY SNAPSHOT (2022)	195
11.1.4	KONINKLIJKE PHILIPS N.V.	198
TABLE 175	KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW	198
FIGURE 34	KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)	199
11.1.5	GE HEALTHCARE	202
TABLE 176	GE HEALTHCARE: COMPANY OVERVIEW	202
FIGURE 35	GE HEALTHCARE: COMPANY SNAPSHOT (2022)	203
11.1.6	BOSTON SCIENTIFIC CORPORATION	205
TABLE 177	BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW	205
FIGURE 36	BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2022)	206
11.1.7	JAPAN LIFELINE	209
TABLE 178	JAPAN LIFELINE: COMPANY OVERVIEW	209
FIGURE 37	JAPAN LIFELINE: COMPANY SNAPSHOT (2022)	209
11.1.8	STEREOTAXIS	211
TABLE 179	STEREOTAXIS: COMPANY OVERVIEW	211
FIGURE 38	STEREOTAXIS: COMPANY SNAPSHOT (2022)	211
11.1.9	MICROPORT SCIENTIFIC CORPORATION	214
TABLE 180	MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW	214
FIGURE 39	MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)	215
11.1.10	BIOTRONIK	218
TABLE 181	BIOTRONIK: COMPANY OVERVIEW	218
11.1.11	ACUTUS MEDICAL	220
TABLE 182	ACUTUS MEDICAL: COMPANY OVERVIEW	220
11.1.12	EP SOLUTIONS SA	222
TABLE 183	EP SOLUTIONS SA: COMPANY OVERVIEW	222
11.1.13	APN HEALTH, LLC	223
TABLE 184	APN HEALTH: COMPANY OVERVIEW	223
 
11.1.14	OSYPKA	224
TABLE 185	OSYPKA: COMPANY OVERVIEW	224
11.1.15	EPMAP-SYSTEM GMBH & CO. KG	225
TABLE 186	EPMAP-SYSTEM GMBH & CO. KG: COMPANY OVERVIEW	225
*Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
11.2	OTHER PLAYERS	226
11.2.1	CATHRX LTD.	226
11.2.2	MERIT MEDICAL SYSTEMS	226
11.2.3	COOK MEDICAL	227
11.2.4	CATHVISION	227
11.2.5	TZ MEDICAL	228
11.2.6	TELEFLEX	228
11.2.7	LEPU MEDICAL TECHNOLOGY	229
11.2.8	CARDIOFOCUS	229
11.2.9	SCHWARZER CARDIOTEK	230
11.2.10	IMRICOR MEDICAL SYSTEMS	230
12	APPENDIX	231
12.1	DISCUSSION GUIDE	231
12.2	KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL	235
12.3	CUSTOMIZATION OPTIONS	237
12.4	RELATED REPORTS	237
12.5	AUTHOR DETAILS	238
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			